BORREGAARD ASA |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 16.15 EUR | +1.44% |
|
-2.81% | +5.15% |
| 08:30am | Transcript : Borregaard ASA, Q2 2024 Earnings Call, Jul 17, 2024 | |
| 07:45am | Borregaard ASA Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 | CI |
| Sales 2024 * | 7.9B 735M 672M | Sales 2025 * | 8.47B 788M 721M | Capitalization | 18.97B 1.77B 1.61B |
|---|---|---|---|---|---|
| Net income 2024 * | 933M 86.81M 79.42M | Net income 2025 * | 1.09B 101M 92.53M | EV / Sales 2024 * | 2.67 x |
| Net Debt 2024 * | 2.09B 194M 178M | Net Debt 2025 * | 1.89B 176M 161M | EV / Sales 2025 * | 2.46 x |
| P/E ratio 2024 * |
20.3
x | P/E ratio 2025 * |
17.5
x | Employees | - |
| Yield 2024 * |
2.37% | Yield 2025 * |
2.73% | Free-Float | 92.13% |
More Fundamentals
* Assessed data
More news
Latest transcript on Borregaard ASA
More news
| 1 day | +1.44% | ||
| 1 week | -2.81% | ||
| Current month | -5.91% | ||
| 1 month | -3.52% | ||
| 3 months | -1.36% | ||
| 6 months | +13.71% | ||
| Current year | +5.15% |
1 week
15.92
16.18
1 month
15.9217.38
Current year
13.6217.44
1 year
12.5217.44
3 years
11.7823.25
5 years
6.3123.25
10 years
6.3123.25
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 67 | 89-12-31 | |
| Director of Finance/CFO | 63 | 87-12-31 | |
Kristin Misund
CTO | Chief Tech/Sci/R&D Officer | 59 | 92-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Terje Andersen
BRD | Director/Board Member | 66 | 12-09-30 |
Margrethe Hauge
BRD | Director/Board Member | 53 | 18-03-31 |
| Director/Board Member | 58 | 12-09-30 |
| Date | Price | Change |
|---|---|---|
| 24-07-17 | 15.92 | 0.00% |
| 24-07-16 | 15.92 | -0.75% |
| 24-07-15 | 16.04 | -0.87% |
| 24-07-12 | 16.18 | +0.50% |
| 24-07-11 | 16.1 | -1.71% |
Delayed Quote Deutsche Boerse AG, July 17, 2024 at 02:23 am EDT
More quotes
Borregaard ASA is a Norway-based biorafinery. The Group provides sustainable products and solutions based on renewable raw materials. Its business model is closely linked to the integrated nature of its biorefinery in Norway, which utilises the three key components of wood cellulose fibres, lignin and sugars to produce a diversified portfolio of products. The Company operates through three business segments. BioSolutions develops, produces and sells biopolymers and biovanillin from lignin. BioMaterials develops, produces and sells speciality cellulose mainly for use as a raw material in the production of cellulose ethers, cellulose acetate and other speciality products. Fine Chemicals consists of second-generation bioethanol and intermediates mainly for contrast agents.
Sector
Specialty Chemicals
Calendar
01:00am
- Q2 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
190
NOK
Average target price
211
NOK
Spread / Average Target
+11.05%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -25.86% | 3.29B | |
| -22.23% | 554M | |
| -32.95% | 359M | |
| -81.65% | 216M | |
| -10.04% | 116M |
- Stock Market
- Equities
- BRG Stock
- BO4 Stock
